ICAD Total Utang marang Modal iCAD, Inc.

ICAD (iCAD, Inc.) - tandha merek perusahaan

The price evolution of iCAD, Inc. (ICAD) reflects a debt load level of 0.01. The business relies on AI solutions for early breast cancer detection, which are deeply integrated into clinic infrastructure. However, legacy licensed products are losing relevance, forcing the firm to transition to a cloud-based format. This process is complicated by fierce competition with hardware vendors and the risk of specialized algorithms becoming obsolete.

Rasio Utang marang Ekuitas: iCAD Inc. (ICAD) kanggo 04.07.2022 - 02.08.2025

Rincian metrik komprehensif lan analitis iCAD (ICAD)

- rega lan prakiraan konsensus rega:
Rega saham iCAD Inc.|ICAD - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar iCAD|ICAD - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham iCAD|ICAD - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku icadmed.com|ICAD - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal iCAD, Inc.|ICAD - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas iCAD Inc.|ICAD - Kewajiban utang agregat|Utang marang nilai buku iCAD|ICAD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan iCAD
Analisis komprehensif perusahaan:ICAD - iCAD, Inc.
Sampel barang iCAD Inc.

This ratio measures the company's degree of dependence on borrowed funds relative to its equity, allowing for an assessment of insolvency risk amid rising interest rates. By analyzing the trend of the total debt-to-equity ratio, an investor can determine whether iCAD, Inc. (ICAD) possesses sufficient resources to develop AI algorithms and modernize hospital software without critical over-leveraging amidst uncertainty regarding insurance payouts.

Pesaing utama

Total Utang marang Modal ONC|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc.|Total Utang marang Modal RVMD|Total Utang marang Modal AAPG (Ascentage Pharma Corp)|CGON - Utang marang Ekuitas|Rasio Utang marang Ekuitas urogen.com URGN|BCAX: Total Utang marang Modal|PSNL - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ERAS|DCTH (Delcath Corp) - Utang marang Modal|YMAB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi aurabiosciences.com (AURA)|Candel Therapeutics (CADL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Accuray Inc (ARAY)|SELLAS Life Sciences Group - Total Utang marang Modal|ACTU - Rasio Total Utang marang Ekuitas|Citius Oncology, Inc. - Rasio Total Utang marang Ekuitas|HURA: Total Utang marang Modal|Utang marang Ekuitas Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal WHWK (Aadi Bioscience, Inc.)|Utang marang Modal TScan|CSBR (Champions Oncology) - Total Utang marang Modal|Koefisien Total Utang marang Modal xbiotech.com (XBIT)|CEL-SCI - Total Utang marang Modal|Rasio Total Utang marang Ekuitas OS Therapies Inc. OSTX|Radiopharm Theranostics Limited - Total Utang marang Modal|ARTV - Total Utang marang Modal|Total Utang marang Modal adlainortye.com|Rasio Utang marang Ekuitas verupharma.com|TPST - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Xilio|RENB (Renovaro Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal MURA (muraloncology.com)|KAPA - Utang marang Ekuitas|Rasio Utang marang Ekuitas OnKure Therapeutics, Inc. OKUR|GDTC: Total Utang marang Modal|Curis, Inc. (CRIS) - Rasio Total Utang marang Ekuitas|apollomicsinc.com - Rasio Total Utang marang Ekuitas|Tharimmune Corporation (THAR) - Koefisien Total Utang marang Modal|ADVB: Total Utang marang Modal|Koefisien Total Utang marang Modal genprex.com|Total Utang marang Modal CLDI (Calidi Biotherapeutics)|Rasio Total Utang marang Ekuitas Sunshine Biopharma Inc. (SBFM)|Total Utang marang Modal XBIO (Xenetic Biosciences, Inc.)|Total Utang marang Modal Salarius Pharma SLRX|Purple Biotech (PPBT) - Total Utang marang Modal|AONC - Rasio Utang marang Ekuitas|BGNE (BeiGene) - Total Utang marang Modal|Checkpoint Therapeutics Inc. (CKPT) - Rasio Total Utang marang Ekuitas|ELEV (Elevation Oncology, Inc.) - Total Utang marang Modal|Total Utang marang Modal IKNA|Utang marang Ekuitas Notable Labs, Ltd. NTBL|Rasio Utang marang Ekuitas viracta.com (VIRX)|MorphoSys - Total Utang marang Modal|Rasio Total Utang marang Ekuitas NAYA Biosciences Inc NAYA|AAPGV (Ascentage Pharma Group Ltd) - Total Utang marang Modal